Outside-to-Inside Signal Through the Membrane TNF-α Induces E-Selectin (CD62E) Expression on Activated Human CD4+ T Cells1
暂无分享,去创建一个
Takahiko Horiuchi | Yoshiyuki Niho | Tomoko Tahira | Hiroshi Tsukamoto | Shigeru Fujita | T. Tahira | T. Horiuchi | N. Hatta | S. Fujita | Y. Niho | H. Tsukamoto | S. Harashima | Kenshi Hayashi | Shin-ichi Harashima | Nobuaki Hatta | Kenshi Hayashi | Chika Morita | Masanori Higuchi | Takuya Sawabe | T. Sawabe | C. Morita | M. Higuchi
[1] T. Horiuchi,et al. C5a Induces Tissue Factor Activity on Endothelial Cells , 1997, Thrombosis and Haemostasis.
[2] T. Horiuchi,et al. Membrane Tumor Necrosis Factor-α (TNF-α) Expressed on HTLV-I-Infected T Cells Mediates a Costimulatory Signal for B Cell Activation—Characterization of Membrane TNF-α , 1997 .
[3] George Kollias,et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.
[4] J. Berman,et al. Tumor necrosis factor alpha induces adhesion molecule expression on human fetal astrocytes , 1992, Journal of Experimental Medicine.
[5] B. Beutler,et al. Unraveling function in the TNF ligand and receptor families. , 1994, Science.
[6] M. Sheetz,et al. Ligation of L-selectin through conserved regions within the lectin domain activates signal transduction pathways and integrin function in human, mouse, and rat leukocytes. , 1997, Journal of immunology.
[7] B. Beutler,et al. The tumor necrosis factor ligand and receptor families. , 1996, The New England journal of medicine.
[8] J. Volanakis,et al. Translational regulation of complement protein C2 expression by differential utilization of the 5'-untranslated region of mRNA. , 1990, The Journal of biological chemistry.
[9] C. Perez,et al. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF , 1988, Cell.
[10] M. Brockhaus,et al. Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cells. , 1989, Cellular immunology.
[11] D. Wallach,et al. Phosphorylation of the 26 kDa TNF precursor in monocytic cells and in transfected HeLa cells. , 1995, Journal of inflammation.
[12] G. Aversa,et al. The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation , 1993, The Journal of experimental medicine.
[13] L. Old,et al. Tumor necrosis factor (TNF). , 1985, Science.
[14] Nicole Nelson,et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.
[15] E. Maggi,et al. Membrane tumour necrosis factor-α is involved in the polyclonal B-cell activation induced by HIV-infected human T cells , 1993, Nature.
[16] S. Inaba,et al. A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese. , 1998, Journal of immunology.
[17] Mengji Lu,et al. Molecular cloning of the woodchuck cytokines: TNF-α, IFN-γ, and IL-6 , 1998, Immunogenetics.
[18] R. Medford,et al. E-selectin gene expression in vascular smooth muscle cells. Evidence for a tissue-specific repressor protein. , 1997, Circulation research.
[19] G S Kansas,et al. Selectins and their ligands: current concepts and controversies. , 1996, Blood.
[20] C. Ferran,et al. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. , 1994, The Journal of clinical investigation.
[21] P. Vassalli,et al. The pathophysiology of tumor necrosis factors. , 1992, Annual review of immunology.
[22] M. Lambert,et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α , 1997, Nature.
[23] T. Horiuchi,et al. Association of Fas/APO-1 gene polymorphism with systemic lupus erythematosus in Japanese. , 1999, Rheumatology.
[24] G. Grau,et al. Both soluble and membrane-associated TNF activate brain microvascular endothelium: relevance to multiple sclerosis , 1997, Molecular Psychiatry.
[25] C. Smith,et al. Reverse signaling via CD30 ligand. , 1996, Journal of immunology.
[26] Yamamura Ken-ichi,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .
[27] D E Ingber,et al. Leukocyte adhesion to vascular endothelium induces E-selectin linkage to the actin cytoskeleton , 1996, The Journal of cell biology.
[28] R. Swerlick,et al. Alternatively processed human E-selectin transcripts linked to chronic expression of E-selectin in vivo. , 1994, Journal of immunology.
[29] D. Gray,et al. CD40 ligand-transduced co-stimulation of T cells in the development of helper function , 1995, Nature.
[30] M. Feldmann,et al. Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF-alpha. , 1997, Journal of immunology.
[31] J. Gamble,et al. Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. , 1993, Journal of immunology.
[32] M. Gimbrone,et al. Novel Roles for E‐Selectin in Endothelial‐Leukocyte Adhesion a , 1997, Annals of the New York Academy of Sciences.
[33] David Wallach,et al. A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in ‘reverse signalling’ , 1999, The EMBO journal.
[34] R. Kriz,et al. The cloning of CD70 and its identification as the ligand for CD27. , 1994, Journal of immunology.
[35] B. Seed,et al. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. , 1989, Science.
[36] T. Decker,et al. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. , 1987, Journal of immunology.
[37] W. Fiers,et al. Two tumour necrosis factor receptors: structure and function. , 1995, Trends in cell biology.
[38] R. Hakem,et al. Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling , 1999, Immunological reviews.
[39] H. Niwa,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.